[CNTA] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[CNTA] Centessa Pharmaceuticals plc
Announcement Date
31-Dec-2020
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- -108.95%
Quarter Report
CNTA's Result
CNTA's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 6,853 0 0 0 0 -
PBT -176,141 -216,954 -381,741 -10,663 -5,061 142.74%
Tax -25,056 -747 114 378 223 -
NP -151,085 -216,207 -381,854 -11,041 -5,284 131.10%
Tax Rate - - - - - -
Total Cost 157,938 216,207 381,854 11,041 5,284 133.68%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin -2,204.65 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -1.57 -2.31 -4.24 -0.08 -0.07 117.50%
EPS Diluted -1.57 -2.31 -4.24 -0.08 -0.07 117.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.